Ahn-Gook Pharmaceuticals Co.,Ltd

Quick facts

Marketed products

• Carvedilol 25mg

Phase 3 pipeline

• AG NPP709syrup · Cardiovascular
  AG NPP709 syrup is a medication that targets the renin-angiotensin system to treat hypertension.
• AG1321001(drug) · Unknown
  AG1321001 is a small molecule drug that targets the molecular target.
• AG2001 · Infectious Diseases
  AG2001 is a small molecule that targets the SARS-CoV-2 main protease.
• AG20011 · Oncology
  AG20011 is a small molecule targeting the PI3K/AKT/mTOR pathway.
• AG20012 · Oncology
  AG20012 is a small molecule that targets the PI3K/AKT/mTOR pathway.
• AG2304R
  AG2304R is an investigational therapeutic in phase 3 development by Ahn-Gook Pharmaceuticals with an undisclosed mechanism of action.
• AG2304T · Oncology
  AG2304T is a small molecule targeting the PD-1 receptor.
• AGLS · Diabetes
  AGLS is a small molecule that targets the SGLT2 receptor.
• AGR tablet · unknown
  AGR tablet is a small molecule drug that targets the molecular target.
• AGS (Experimental) · Oncology
  AGS is an experimental drug that targets the PD-1/PD-L1 pathway.
• AGSAVI
  AGSAVI is an investigational therapeutic agent in Phase 3 development by Ahn-Gook Pharmaceuticals, but its specific mechanism of action is not publicly disclosed.
• AGSCT101 12.5mg
• AGSPT201 Tab contains S-pantoprazole · Gastroenterology
  S-pantoprazole inhibits the proton pump in gastric parietal cells, reducing gastric acid secretion.
• AGT2
  AGT2 is an investigational drug with unknown mechanism of action.
• AGT2, AGZ
• AGT4 · Cardiovascular
  AGT4 is an angiotensin II receptor antagonist.
• AGT4, AGZ · Cardiovascular
  AGT4 and AGZ are angiotensin II receptor blockers.
• AGU (Active Comparator)
  AGU is an active comparator used in clinical trials.

Phase 1 pipeline

• AG1502
• AG2202R
• AG2202T
• AG2304
• AG23041 and AG23042
• AGSAV301
• AGSPT_10
• AGSPT_20
• AGSPT_40
• AGSPT_L20
• Pantoprazole_20
• Pantoprazole_40

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Ahn-Gook Pharmaceuticals Co.,Ltd portfolio CI brief
• Ahn-Gook Pharmaceuticals Co.,Ltd pipeline updates RSS